Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.05.01.721678

Partitioning the roots of interactions between microbes (PRISM): environment-supplied resources versus species-produced mediators

Abstract

Microbial species in a community can interact through competition for resources present in the environment, as well as inhibition or facilitation by metabolites produced by other species. Understanding the relative contribution of these two types of interaction will help us modulate bacterial interactions more effectively. Our work focuses on partitioning the impact of metabolites that mediate the interactions between bacteria into the contribution of resources present in the environment versus that of mediators released as by-products of cellular activities. For this, we create a range of conditions in which the ratio of environmentally supplied resources (R) and the species-produced metabolites (M) is modulated to infer the contribution of each to the overall interaction. We performed this assay with six different nasal bacterial strains and saw an array of outcomes in terms of how secreted metabolites by one strain affected other nasal strains. Metabolites produced by Staphylococcus suppressed the growth of most strains tested. In contrast, metabolites produced by commensal strains such as Corynebacterium accolens and Corynebacterium tuberculostearicum could aid the growth of Staphylococcus aureus and Staphylococcus epidermidis strains. Interestingly, the growth of Staphylococcus epidermidis benefited from metabolites produced by four out of the five strains tested. Our proposed assay offers additional insights into the roots of bacterial interactions, enabling applications such as engrafting helpful probiotics and knocking out harmful bacteria.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Warrier, V., Momeni, B.. 2026-05-02. Partitioning the roots of interactions between microbes (PRISM): environment-supplied resources versus species-produced mediators. https://doi.org/10.64898/2026.05.01.721678

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗